Literature DB >> 8607584

Peptide YY: a potential proabsorptive hormone for the treatment of malabsorptive disorders.

C D Liu1, T Aloia, T E Adrian, T R Newton, A J Bilchik, M J Zinner, S W Ashley, D W McFadden.   

Abstract

Peptide YY (PYY) is a 36 amino acid peptide that is released from the endocrine cells of the distal ileum, colon, and rectum following a meal. PYY is strongly proabsorptive in the small intestine. We studied the effects of intravenous PYY on colonic water and electrolyte transport in awake dogs. Dogs had 20 cm neurovascularly intact colon Thiry-Vella fistulas (TVS) surgically constructed. Colonic transport was studied in three experimental groups. Group 1 animals received a standard mixed meal. Group 2 animals were unfed and received intravenous PYY and 100 pmol/kg/hr for two hours. This dose of PYY has previously been shown to simulate the plasma levels of PYY normally seen after a meal. Group 3 received intravenous PYY at the same dose in addition to a mixed meal. Our study shows an increase in colonic water, Na+, and Cl- absorption after a meal (P < 0.05). Infusion of PYY at a 100 pmol/kg/hr was significantly proabsorptive beginning at 60 minutes (P < 0.01). Infusion of PYY in addition to a meal further increased absorption (P < 0.05). PYY is a potent proabsorptive agent in the colon of the conscious dog. PYY, or its analogs, may be useful clinical agents in intestinal malabsorptive disorders or after bowel resection.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8607584

Source DB:  PubMed          Journal:  Am Surg        ISSN: 0003-1348            Impact factor:   0.688


  17 in total

1.  Postprandial absorptive augmentation of water and electrolytes in the colon requires intraluminal glucose.

Authors:  Michael L Kendrick; Nicholas J Zyromski; Toshiyuki Tanaka; Judith A Duenes; Karen Libsch; Michael G Sarr
Journal:  J Gastrointest Surg       Date:  2002 May-Jun       Impact factor: 3.452

Review 2.  Neuropeptide Y Y2 receptor in health and disease.

Authors:  S L Parker; A Balasubramaniam
Journal:  Br J Pharmacol       Date:  2007-09-10       Impact factor: 8.739

3.  Gastrointestinal hormonal responses on GPR119 activation in lean and diseased rodent models of type 2 diabetes.

Authors:  S Patel; O J Mace; I R Tough; J White; T-A Cock; U Warpman Berglund; M Schindler; H M Cox
Journal:  Int J Obes (Lond)       Date:  2014-01-23       Impact factor: 5.095

Review 4.  New advances in models and strategies for developing anti-obesity drugs.

Authors:  Gilbert W Kim; Jieru E Lin; Erik S Blomain; Scott A Waldman
Journal:  Expert Opin Drug Discov       Date:  2013-04-29       Impact factor: 6.098

Review 5.  Regulation of appetite to treat obesity.

Authors:  Gilbert W Kim; Jieru E Lin; Michael A Valentino; Francheska Colon-Gonzalez; Scott A Waldman
Journal:  Expert Rev Clin Pharmacol       Date:  2011-03       Impact factor: 5.045

6.  Characterization of two novel proabsorptive peptide YY analogs, BIM-43073D and BIM-43004C.

Authors:  D A Litvak; H Iseki; B M Evers; G H Greeley; M R Hellmich; K Iwase; A Balasubramaniam; C M Townsend
Journal:  Dig Dis Sci       Date:  1999-03       Impact factor: 3.199

7.  Cholera toxin-induced secretion in rats is reduced by a soluble fiber, gum arabic.

Authors:  J L Turvill; R A Wapnir; M A Wingertzahn; S Teichberg; M J Farthing
Journal:  Dig Dis Sci       Date:  2000-05       Impact factor: 3.199

8.  Foxa1 and Foxa2 control the differentiation of goblet and enteroendocrine L- and D-cells in mice.

Authors:  Diana Z Ye; Klaus H Kaestner
Journal:  Gastroenterology       Date:  2009-09-06       Impact factor: 22.682

9.  Current trends in targeting the hormonal regulation of appetite and energy balance to treat obesity.

Authors:  Michael A Valentino; Francheska Colon-Gonzalez; Jieru E Lin; Scott A Waldman
Journal:  Expert Rev Endocrinol Metab       Date:  2010-09-01

Review 10.  Obesity pharmacotherapy: what is next?

Authors:  Francheska Colon-Gonzalez; Gilbert W Kim; Jieru E Lin; Michael A Valentino; Scott A Waldman
Journal:  Mol Aspects Med       Date:  2012-10-24
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.